FDA Inspection 1268116 - Guangxi Yulin Pharmaceutical Group Co. Ltd. - March 21, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Guangxi Yulin Pharmaceutical Group Co. Ltd., with an inspection on March 21, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Guangxi Yulin Pharmaceutical Group Co. Ltd.
Inspection Date: March 21, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations

Open in Dashboard

ID · 82a89afe-506e-4e84-9dd2-02a225853a04